OOIR: Observatory of International Research

Papers

(The H4-Index of Expert Review of Anti-Infective Therapy is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Janus kinase inhibitors for hospitalized patients with COVID-19: a meta-analysis of randomized controlled trials	95
Part 1: Understanding the role of Malassezia spp. in skin disorders: Malassezia yeasts as commensal or pathogenic organisms of human and a	85
Emerging issues on Staphylococcus aureus endocarditis and the role in therapy of daptomycin plus fosfomycin	66
Sulbactam-durlobactam for the treatment of Acinetobacter baumannii-calcoaceticus complex	65
The efficacy and safety of ceftolozane-tazobactam in the treatment of GNB infections: a systematic review and meta-analysis of clinical studies	65
The efficacy and safety of complement C5a inhibitors for patients with severe COVID-19: a systematic review and meta-analysis	62
A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future	54
Visceral leishmaniasis elimination in India: progress and the road ahead	50
Neonatal ocular prophylaxis in the United States: is it still necessary?	43
Optic and peripheral neuropathy associated with short and prolonged administration of tedizolid: a review	39
Challenges in preserving antibiotic effectiveness: time for a novel approach	38
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies	37
Nontuberculous mycobacterial pulmonary disease and the potential role of SPR720	36
Preventing healthcare-related infections among older adults: a focus on cross-transmission of antibiotic-resistant bacteria	35
Tackling antimicrobial resistance in sub-Saharan Africa: challenges and opportunities for implementing the new people-centered WHO guidelines	35
The emergence of Japanese encephalitis as a public health concern in New South Wales Australia	34
Decoding drug resistance in Mycobacterium tuberculosis complex: genetic insights and future challenges	32
Accuracy of gradient diffusion method for susceptibility testing of dalbavancin and comparators	29
All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies	29
Response to: ‘letter to the editor: “A multifaceted strategy is needed to limit the over-the-counter sale of antimicrobials “’	28
Can inhaled antifungals provide a viable solution for treatment-refractory pulmonary fungal infections?	26
New and emerging roles for inhalational and direct antifungal drug delivery approaches for treatment of invasive fungal infections	25
Treatment of vaginitis caused by non-albicans Candida species	24
Safety and efficacy of Paxlovid in the treatment of adults with mild to moderate COVID-19 during the omicron epidemic: a multicentre study from China	24